Investors

banner

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Semler Scientific Reports First Quarter 2023 Financial Results
2023 Q1 highlights: Revenue was $18.2 million , an increase of 30% compared to the corresponding period of 2022 Net income was $5.0 million , an increase of 48% compared to the corresponding period of 2022 Cash, cash equivalents and short-term investments of $43.0 million SANTA CLARA, Calif.
View HTML
Toggle Summary Semler to Report First Quarter 2023 Financial Results and Host Conference Call on May 10, 2023
SANTA CLARA, Calif. , May 1, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended
View HTML
Toggle Summary Semler Scientific Names Doug Murphy-Chutorian, M.D. as Interim CEO
SANTA CLARA, Calif. , April 28, 2023 /PRNewswire/ -- The board of directors of Semler Scientific, Inc. (Nasdaq: SMLR), is pleased to announce that it has appointed Doug Murphy-Chutorian , M.D., former CEO and a current member of the board of directors as chief executive officer (CEO) on an interim
View HTML
Toggle Summary Semler Scientific Announces Appointment of Eric Semler and William Chang as Directors
Eric Semler Appointed as Chairman SANTA CLARA, Calif. , April 19, 2023 /PRNewswire/ -- - Semler Scientific, Inc. (Nasdaq: SMLR) today announced that Eric Semler and William H.C. Chang (together, the "Investors"), who collectively beneficially own more than 20% of Semler Scientific's outstanding
View HTML
Toggle Summary Semler Scientific to Participate in the 22nd Annual Needham Virtual Healthcare Conference
SANTA CLARA, Calif. , April 5, 2023 /PRNewswire/ -- Semler Scientific, Inc. ( Nasdaq : SMLR ), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Wayne T .
View HTML
Toggle Summary Semler Scientific Comments on CMS Risk Adjustment Changes in the 2024 Medicare Advantage and Part D Final Rate Announcement
SANTA CLARA, Calif. , April 3, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, commented on the recent Centers for Medicare and Medicaid Services (CMS) 2024
View HTML
Toggle Summary Semler Scientific Reports Fourth Quarter and Full Year 2022 Financial Results
2022 Q4 and Full Year highlights   compared to the corresponding period of 2021: Fourth quarter revenue was $13.8 million , an increase of 20% Fourth quarter net income was $3.2 million , an increase of 113% Full year revenue was $56.7 million , an increase of 7% Full year net income was $14.3
View HTML
Toggle Summary Semler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO Effective April 3, 2023
SANTA CLARA, Calif. , March 21, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, announces that Doug Murphy-Chutorian , M.D.
View HTML
Toggle Summary Semler to Report Fourth Quarter and Year End 2022 Financial Results and Host Conference Call on March 21, 2023
SANTA CLARA, Calif. , March 10, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR ), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the fourth quarter and
View HTML
Toggle Summary Semler Announces Clinical Study Published Using QuantaFlo® as an Aid for Diagnosis of Heart Dysfunction in the Primary Care Setting
SANTA CLARA, Calif. , March 1, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers (HCPs), today announced the publication of a study in the peer-reviewed Journal of
View HTML

Semler Scientific

Contact us
Semler Scientific, Inc.
2344 Walsh Avenue
Santa Clara, CA 95051

Call us toll-free at
877-774-4211